Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD.
about
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDLong-Term Outcomes with Medications for Attention-Deficit Hyperactivity DisorderPharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulantsA randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHDChanges in behavior as side effects in methylphenidate treatment: review of the literatureEfficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adultsDexmethylphenidate for attention deficit hyperactivity disorder.Open-label dose optimization of methylphenidate modified release long acting (MPH-LA): a post hoc analysis of real-life titration from a 40-week randomized trial.An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adultsMethylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.Good vibrations--effects of whole body vibration on attention in healthy individuals and individuals with ADHD.Treating attention-deficit/hyperactivity disorder in adults: focus on once-daily medications.Long-term (1 year) safety and efficacy of methylphenidate modified-release long-acting formulation (MPH-LA) in adults with attention-deficit hyperactivity disorder: a 26-week, flexible-dose, open-label extension to a 40-week, double-blind, randomiseRecognizing ADHD in adults with comorbid mood disorders: implications for identification and management.The safety and efficacy of methylphenidate and dexmethylphenidate in adults with attention deficit/hyperactivity disorder.Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study.The safety of extended-release drug formulations for the treatment of ADHD.Prescription stimulant medication misuse: Where are we and where do we go from here?Intranasal versus oral administration of lisdexamfetamine dimesylate: a randomized, open-label, two-period, crossover, single-dose, single-centre pharmacokinetic study in healthy adult men.Cardiovascular safety of stimulant medications for pediatric attention-deficit hyperactivity disorder.A Long-Term, Open-Label, Safety Study of Triple-Bead Mixed Amphetamine Salts (SHP465) in Adults With ADHD.Whole-body vibration improves cognitive functions of an adult with ADHD.Zur Wirksamkeit pharmakologischer und psychotherapeutischer Therapien bei Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter: Eine empirische Metaanalyse
P2860
Q21260332-D184D039-D635-4B6F-A60E-9B592E0C01B2Q22241421-1A205D3D-7D19-49F8-8661-C85DBEFAAA3CQ22241445-FD6C9906-9A91-4A3A-A3FC-69AD2B5E3D08Q24632726-C863D3FD-9894-4B91-812D-E88DD52394D2Q28078623-CBF1A7D0-DC40-4A7B-B2DA-5D3B8AD4328CQ28246506-54628E2C-33E3-4F6A-B02B-29D5E50164B9Q33513714-24D4A369-B963-401E-8DAC-D7D7AB2612B2Q34085116-49DE86EA-AF53-47A8-97C8-BA6074013C92Q34220004-84A8D8A7-35ED-4EBF-8687-8D168374F752Q34394522-C88AF82D-90E3-401A-804B-9CB7AC16CB42Q34565497-0678D5E4-062F-424E-938B-C8ED084B49C8Q35109177-4B5FBFB5-1FBF-49FB-AA0C-46FC69B03A1DQ35833310-2A3D2372-C359-4A7D-A548-7F90202DE7ECQ36364178-778EDE6E-4AC3-4F38-BB49-9026594B56B2Q37612683-66B65310-CEE9-4790-987D-E40F7F8B5381Q38122148-5CCD93F1-17C3-4F54-8E53-5BC1E3D78E87Q38592540-53FA37E9-E3C9-4F99-A89F-71B219C0D96AQ38732635-F8E63E90-EC0C-46C5-B67B-AAEAA26EB46DQ38815927-AA5492C8-217A-4A7A-B1DA-92ADF67675CAQ42599423-AA6F4752-0E75-4818-8D06-FE4186AACFEAQ42671264-A85DB134-B962-434B-B935-4B649B0D8AD6Q47741604-289A9DD7-75BF-4622-B257-C4888B024010Q50648391-A71A191A-BEA3-4029-93AE-7879D82F29FCQ56962633-C4544CC4-7F57-44F4-9E57-82ED1872FCDC
P2860
Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Long-term effectiveness and sa ...... elease capsules in adult ADHD.
@en
Long-term effectiveness and sa ...... elease capsules in adult ADHD.
@nl
type
label
Long-term effectiveness and sa ...... elease capsules in adult ADHD.
@en
Long-term effectiveness and sa ...... elease capsules in adult ADHD.
@nl
prefLabel
Long-term effectiveness and sa ...... elease capsules in adult ADHD.
@en
Long-term effectiveness and sa ...... elease capsules in adult ADHD.
@nl
P2093
P2860
P356
P1476
Long-term effectiveness and sa ...... release capsules in adult ADHD
@en
P2093
James J McGough
Rafael Muniz
Thomas Spencer
P2860
P304
P356
10.1177/1087054708320397
P50
P577
2009-03-01T00:00:00Z